Neuroprotective Action of the CB1/2 Receptor Agonist, WIN 55,212-2, against DMSO but Not Phenobarbital-Induced Neurotoxicity in Immature Rats.

Neurotoxicity Research
Megan N Huizenga, Patrick A Forcelli

Abstract

The developing brain is uniquely susceptible to drug-induced increases in programmed cell death or apoptosis. Many compounds, including anticonvulsant drugs, anesthetic agents, and ethanol, when administered in a narrow postnatal window in rodents, result in increased pruning of neurons. Here, we report that dimethyl sulfoxide (DMSO) triggers widespread neurodegeneration in the immature (postnatal day, P7) rat brain, an effect consistent with a prior report in neonatal mice. We found that the synthetic cannabinoid receptor agonist WIN 55,212-2 (WIN) exerts a neuroprotective effect against DMSO-induced cell death. We extended these findings to determine if WIN is neuroprotective against another drug class known to increase developmental cell death, namely antiseizure drugs. The antiseizure drug phenobarbital (PB) remains the primary treatment for neonatal seizures, despite significantly increasing cell death in the developing rodent brain. WIN exerts antiseizure effects in immature rodent seizure models, but increases the toxicity associated with neonatal ethanol exposure. We thus sought to determine if WIN would protect against or exacerbate PB-induced cell death. Unlike either the prior report with ethanol or our present findi...Continue Reading

References

Jul 1, 1992·Progress in Neurobiology·I FerrerC Auladell
Jan 12, 2001·Journal of Neurophysiology·G Gerdeman, D M Lovinger
Jul 13, 2001·Neurobiology of Disease·K DikranianJ W Olney
Oct 2, 2001·Journal of Neurochemistry·H H HansenH S Hansen
Nov 1, 2002·Brain Pathology·John W OlneyChysanthy Ikonomidou
Nov 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Petra BittigauChrysanthy Ikonomidou
Jul 11, 2003·Annals of the New York Academy of Sciences·Petra BittigauChrysanthy Ikonomidou
Oct 4, 2003·Science·Giovanni MarsicanoBeat Lutz
Mar 17, 2004·Trends in Pharmacological Sciences·John W OlneyChrysanthy Ikonomidou
Feb 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Belén G RamírezMaría L de Ceballos
Mar 4, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Juergen BardutzkyMarc Fisher
Jan 16, 2007·Trends in Pharmacological Sciences·Tibor HarkanyKen Mackie
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Oct 30, 2007·Cerebral Cortex·Nicolas HeckHeiko J Luhmann
Dec 11, 2007·Annals of Neurology·Henrik H HansenChrysanthy Ikonomidou
Dec 23, 2008·Neurobiology of Disease·Jennifer L HanslickNuri B Farber
Mar 25, 2009·Brain & Development·Chrysanthy Ikonomidou
May 16, 2009·Pharmacological Reports : PR·Stanley W Jacob, Jack C de la Torre
Sep 30, 2010·CNS Neuroscience & Therapeutics·Aoife GowranVeronica A Campbell
Dec 24, 2010·British Journal of Pharmacology·Luciano De PetrocellisVincenzo Di Marzo
Mar 23, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·A J Sánchez, A García-Merino
Jul 19, 2012·Annual Review of Psychology·Raphael Mechoulam, Linda A Parker
Nov 12, 2013·Epilepsy Research·Patrick A ForcelliAlexei Kondratyev
Sep 10, 2015·The New England Journal of Medicine·Daniel Friedman, Orrin Devinsky
Feb 13, 2016·Epilepsia·Lindsay BrownPatrick A Forcelli
Jul 28, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Tiziana BisognoMauro Maccarrone

❮ Previous
Next ❯

Methods Mentioned

BETA
electron microscopy

Software Mentioned

GraphPad Prism
GraphPad
IMAGEJ

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis